Trial Profile
Maximizing Treatment Outcome in OCD.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 10 Nov 2015 Results assessing exposure and response prevention published in the Journal of Clinical Psychiatry (n = 32).
- 11 Sep 2013 Primary endpoint 'Yale-Brown-Obsessive-Compulsive-Scale' has been met for cognitive behavioural therapy but not for risperidone according to results published in JAMA Psychiatry.
- 11 Sep 2013 Results published in JAMA Psychiatry.